| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Sales - devices and disposables | 60 | 117 | - | - |
| Cost of goods sold | 25 | 38 | - | - |
| Gross profit | 35 | 79 | - | - |
| Research and development | 136 | 133 | 74 | 111 |
| Sales and marketing | 22 | 51 | 73 | 76 |
| General and administrative | 362 | 658 | 267 | 374 |
| Gain / (loss) from extinguishment of debt | - | - | -16 | - |
| Total operating expenses | 520 | 842 | 414 | 561 |
| Change in fair value of derivative liability | - | - | 52 | -1 |
| Interest income | - | 0 | - | - |
| Loss from operations | -485 | -763 | -414 | -561 |
| Interest expense | 129 | 157 | 147 | 108 |
| Interest income | 0 | - | - | - |
| Change in fair value of derivative liability | -37 | 30 | - | - |
| Gain from forgiveness of debt | 15 | - | - | - |
| Loss from extinguishment of debt | -106 | 0 | - | 16 |
| Gain from forgiveness of debt | - | 15 | - | - |
| Other income | 0 | - | - | - |
| Total other income (expense) | - | -48 | -13 | -93 |
| Total other income (expense) | -257 | 64 | 98 | - |
| Loss before income taxes | -742 | -811 | -427 | -654 |
| Provision for income taxes | 0 | 0 | - | - |
| Net loss | -742 | -811 | -427 | -654 |
| Preferred stock dividends | 43 | 45 | 36 | 38 |
| Net loss attributable to common stockholders | -785 | -856 | -463 | -692 |
| Basic | -0.01 | -0.01 | -0.01 | -0.01 |
| Basic | 81,689,000 | - | - | 57,039,000 |
| Diluted | -0.01 | -0.01 | -0.01 | -0.01 |
| Diluted | 81,689,000 | 78,838,000 | 68,291,000 | 57,039,000 |
GUIDED THERAPEUTICS INC (GTHP)
GUIDED THERAPEUTICS INC (GTHP)